Attachment F- IRB Waiver Letter

Institutional Review Board Initial Determination
Principal Investigator/Project Director:
Project Title:

Ryan White ACA (Affordable Care Act)

Sponsor Agency:
Abt IRB #:

Michael Costa

HRSA/HAB

0723

Initial Determination Status:

Study Exempt from IRB Review

Please note the following requirements:
Abt Associates IRB #: This study has been assigned the following Abt Associates IRB# 0723.
Please refer to this number in your future correspondence with the Board.
Change in Study Status: This exemption only applies to the protocol submitted to the IRB for
review at this time. Should there be changes to the protocol in the future, the study should be
resubmitted to determine whether further IRB review is required.
Questions or concerns regarding this determination should be directed to the Abt Associates’ IRB
at irb@abtassoc.com.

Teresa Doksum, Ph.D., M.P.H.
IRB Chair
Abt Associates Inc.
55 Wheeler Street
Cambridge, MA 02138
617-349-2896
irb@abtassoc.com
Cc:

Date:

February 14, 2014